Andales, Rhianne B.
HRN: 21-15-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/12/2024
12/19/2024
IV
500mg
Q6hours
ARTI
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes